-+ 0.00%
-+ 0.00%
-+ 0.00%

Aura Biosciences Q4 EPS $(0.37) Beats $(0.45) Estimate

Benzinga·03/30/2026 11:17:33
Listen to the news
Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.45) by 17.78 percent. This is a 28.85 percent increase over losses of $(0.52) per share from the same period last year.